Pre-market Movers For Aug 19 (SUPN, LLEN, GTXI)

(RTTNews) - Gainers:

Supernus Pharmaceuticals, Inc. (SUPN) is rising 33 percent to $8.87. The company announced that it has received final approval from the FDA for Trokendi XR, a novel once-daily extended release formulation of topiramate for the treatment of epilepsy.

Decliners:

L & L Energy, Inc. (LLEN) is down 11 percent to $2.41. The company announced the formation of a strategic partnership to execute an acquisition. The company also announced that it has decided to wind down operations in Hong Xing Washing facility due to increased needs of capital expenditures. The company said it has decided Hong Xing will not be accretive to company in the long run and has stopped Hong Xing's washing operations.

GTX Inc. (GTXI) is plunging 66 percent to $1.38 . The company announced results of two of its Phase 3 enobosarm clinical trials, the POWER trials, in patients with non-small cell lung cancer or NSCLC receiving chemotherapy. The company announced that the clinical trials failed to meet the overall criteria for the co-primary responder endpoints of lean body mass and physical function as agreed upon with the FDA.